<rss version="2.0" xmlns:a10="http://www.w3.org/2005/Atom"><channel><title>RSC - RSC Med. Chem. latest articles</title><link>http://pubs.rsc.org/en/Journals/Journal/MD</link><description>RSC - RSC Med. Chem. latest articles</description><copyright>Copyright (c)  The Royal Society of Chemistry</copyright><lastBuildDate>Sun, 03 May 2026 15:40:21 Z</lastBuildDate><category>RSC - RSC Med. Chem. latest articles</category><image><url>http://pubs.rsc.org/content/NewImages/rsc_publishing_logo.gif</url><title>RSC - RSC Med. Chem. latest articles</title><link>http://pubs.rsc.org/en/Journals/Journal/MD</link></image><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00096G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00096G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00096G</link><title>Light-Controlled Inhibition of Gram-Positive Bacteria by Photoswitchable Amphiphilic Lipids (PALs)</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00096G, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Guilherme Fernandes, Seong Heun Kim, Charlotte K Hind, Jessica Furner-Pardoe , Janis Romanopulos, Christian D. Lorenz, James Mason, J. Mark Sutton, Daniele Castagnolo&lt;br/&gt;Amphiphilic lipids are potent membrane-disrupting antibacterials, but their activity cannot normally be modulated after administration. Here we report photoswitchable amphiphilic lipids (PALs) that enable reversible, light-controlled modulation of antibacterial potency...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-01T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Guilherme Fernandes</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Seong Heun Kim</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Charlotte K Hind</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jessica Furner-Pardoe </creator><creator xmlns="http://purl.org/dc/elements/1.1/">Janis Romanopulos</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Christian D. Lorenz</creator><creator xmlns="http://purl.org/dc/elements/1.1/">James Mason</creator><creator xmlns="http://purl.org/dc/elements/1.1/">J. Mark Sutton</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Daniele Castagnolo</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00179C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00179C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00179C</link><title>Development of novel chalcone-based quinazoline derivatives as dual VEGFR-2 and EGFR inhibitors</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00179C, Research Article&lt;/div&gt;&lt;div&gt;Zainab  Elsayed, Haytham O. Tawfik, Loah R Hemeda, Mohamed S. Nafie, Hadia Almahli, Rehan  Monir, Ikhlas A Sindi, Eslam Elkaeed, Mostafa M Elbadawi, Mahmoud A. El Hassab, Wagdy M. Eldehna&lt;br/&gt;As possible dual VEGFR-2/EGFR inhibitors, a new set of quinazoline-chalcone hybrid compounds (8a-h and 11a-h) was logically developed and synthesized. The synthesized compounds' chemical structures were verified by high-resolution mass...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-01T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Zainab  Elsayed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Haytham O. Tawfik</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Loah R Hemeda</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed S. Nafie</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hadia Almahli</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rehan  Monir</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ikhlas A Sindi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Eslam Elkaeed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mostafa M Elbadawi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mahmoud A. El Hassab</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wagdy M. Eldehna</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00069J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00069J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00069J</link><title>Small-Molecule Therapeutics for Diabetic Retinopathy: From VEGFR Inhibitors to Emerging Non-VEGF Targets</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00069J, Review Article&lt;/div&gt;&lt;div&gt;Yan  Li, Wenfang Zhang, Yin-Liang Bai, Honghua Zhang&lt;br/&gt;Diabetic retinopathy (DR) remains a leading cause of vision loss worldwide and is driven largely by chronic microvascular dysfunction dominated by vascular endothelial growth factor (VEGF) signaling. Although biologics have...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-01T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Yan  Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wenfang Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yin-Liang Bai</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Honghua Zhang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00023A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00023A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00023A</link><title>Recent advances in the development of acridine-based hybrids with antiproliferative activity</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00023A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00023A, Review Article&lt;/div&gt;&lt;div&gt;Mahdi Gallala, Najeh Tka, Sonia Aroui&lt;br/&gt;Exploring the evolution of acridine hybrids as multi-targeted anticancer agents, this review synthesizes key SAR insights and design principles. It evaluates the impact of hybridization on potency, selectivity, and preclinical development.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-14T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mahdi Gallala</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Najeh Tka</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sonia Aroui</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00088F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00088F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00088F</link><title>Beyond acrylamide: a structure-guided investigation of covalent warheads in the development of CDK7 inhibitors</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00088F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00088F, Research Article&lt;/div&gt;&lt;div&gt;Yu Cao, Yiqing Huang, Yunlong Pan, Jialuo Mao, Lixin Gao, Jiankang Zhang, Huajian Zhu, Shourong Liu, Rangxiao Zhuang, Yang Liu, Yubo Zhou, Jiaan Shao&lt;br/&gt;To achieve covalent CDK7 inhibitors with superior antiproliferative activity and enhanced selectivity, we designed and synthesized a series of covalent CDK7 inhibitors bearing diverse warheads based on the THZ1 scaffold.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-10T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Yu Cao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yiqing Huang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yunlong Pan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jialuo Mao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lixin Gao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiankang Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Huajian Zhu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shourong Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rangxiao Zhuang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yang Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yubo Zhou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiaan Shao</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00063K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00063K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00063K</link><title>Histone Deacetylases-Based Dual Inhibitors: Research Progress Focusing on Non-Small Cell Lung Cancer Therapy</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00063K, Review Article&lt;/div&gt;&lt;div&gt;Zhiguang Yang, Zihao  Liu&lt;br/&gt;Epigenetic regulation plays a pivotal role in the initiation, progression and drug resistance mechanisms of non-small cell lung cancer (NSCLC). As important epigenetic regulatory enzymes, histone deacetylases (HDACs) are aberrantly...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-29T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Zhiguang Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zihao  Liu</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00091F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00091F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00091F</link><title>The effects of bioisostere substitution on the antimicrobial and physicochemical properties of supramolecular self-associating amphiphiles</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00091F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2151-2156&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00091F, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Pinky K. Naicker, Mariam Yacoub, Lisa J. White, Dominick E. Balderston, Perry A. Hailey, J. Mark Sutton, Charlotte K. Hind, Jennifer R. Hiscock&lt;br/&gt;The use of bioisosteres enhances the antimicrobial activity for a range of supramolecular self-associating amphiphiles.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-23T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Pinky K. Naicker</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mariam Yacoub</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lisa J. White</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dominick E. Balderston</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Perry A. Hailey</creator><creator xmlns="http://purl.org/dc/elements/1.1/">J. Mark Sutton</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Charlotte K. Hind</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jennifer R. Hiscock</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01086A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01086A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01086A</link><title>Design and biological evaluation of triagonist GLP-1R/GCGR/GIPR peptides as potential therapeutic agents for diabetes and obesity</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01086A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2113-2129&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01086A, Research Article&lt;/div&gt;&lt;div&gt;Iwona Kalinowska, Alicja Gawalska, Paulina Kasprzycka, Michał Stępniewski, Piotr Rózga, Aneta Pałka, Andrii Shubin, Katarzyna Bukato, Marlena Gałązka, Ewa Burchard, Paulina Zielińska-Świder, Albert Jaworski, Marcin Feder&lt;br/&gt;Rational design and molecular modelling enabled the development of potent GLP-1/GIP/GCGR triagonists with robust &lt;em&gt;in vitro&lt;/em&gt; activity and efficacy comparable to established incretin agonists.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-19T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Iwona Kalinowska</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alicja Gawalska</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Paulina Kasprzycka</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Michał Stępniewski</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Piotr Rózga</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Aneta Pałka</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Andrii Shubin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Katarzyna Bukato</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marlena Gałązka</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ewa Burchard</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Paulina Zielińska-Świder</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Albert Jaworski</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marcin Feder</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01127B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01127B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01127B</link><title>Discovery of dihydrospiro[cyclopropane-1,7′-pyrrolo[3,4-d]pyrimidine] derivatives as novel ATR inhibitors</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01127B" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2067-2080&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01127B, Research Article&lt;/div&gt;&lt;div&gt;Xiaozhen Chen, Yunbo Qian, Yitong Guo, Junfei Li, Lei Xu, Xingxing Zeng, Kailong Jiang, Yubo Zhou, Jia Li, Tao Liu&lt;br/&gt;Novel ATR inhibitors were developed using a scaffold hopping strategy, with compound &lt;strong&gt;10h&lt;/strong&gt; exhibiting favorable activity.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-16T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Xiaozhen Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yunbo Qian</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yitong Guo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Junfei Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lei Xu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xingxing Zeng</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kailong Jiang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yubo Zhou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jia Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tao Liu</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01149C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01149C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01149C</link><title>Design, synthesis and biological assessment of erlotinib-1,2,3-triazole derivatives for anticancer applications</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01149C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2053-2066&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01149C, Research Article&lt;/div&gt;&lt;div&gt;Qiyan Yao, Kexin Qu, Lan Wang, Mengmeng Huang, Longfei Mao, Sanqiang Li&lt;br/&gt;A series of novel erlotinib derivatives incorporating 1,2,3-triazole moieties were synthesized and evaluated for their anti-hepatocellular carcinoma activity both &lt;em&gt;in vitro&lt;/em&gt; and &lt;em&gt;in vivo&lt;/em&gt;.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-12T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Qiyan Yao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kexin Qu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lan Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mengmeng Huang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Longfei Mao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sanqiang Li</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00049E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00049E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00049E</link><title>Peptides as multifunctional linchpins in targeted drug conjugates</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00049E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1794-1810&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00049E, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Xue Li, Yuechen Qian, Jiongjia Cheng, Qian Chu&lt;br/&gt;Multifunctional roles of peptides in peptide–drug conjugates.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-09T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Xue Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yuechen Qian</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiongjia Cheng</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qian Chu</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01118C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01118C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01118C</link><title>Design, synthesis, and biological evaluation of X19: a matrine pyrazole derivatives therapeutic candidate</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01118C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2002-2014&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01118C, Research Article&lt;/div&gt;&lt;div&gt;Tingguo Xu, Suyi Dai, Zhouxing Hu, Anqi Ou, Xingdong Wang, Lisheng Wang&lt;br/&gt;A series of novel matrine-pyrazole derivatives were designed and synthesized through structural modification of the natural alkaloid matrine to enhance its antitumor efficacy.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-05T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Tingguo Xu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Suyi Dai</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhouxing Hu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anqi Ou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xingdong Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lisheng Wang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01098E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01098E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01098E</link><title>Extending the architecture of bolaamphiphilic disinfectants: an investigation of octenidine and isooctenidine analogs</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01098E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2144-2150&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01098E, Research Article&lt;/div&gt;&lt;div&gt;Danielle E. Talbot, Caroline M. Casey, Elise L. Bezold, Kelsi Membrino, Alina Y. Muldagaliyeva, William M. Wuest, Kevin P. C. Minbiole&lt;br/&gt;Octenidine and isooctenidine are equally potent disinfectant architectures, capitalizing on a bolaamphiphilic structure to confer significant activity to two dozen QACs tested against a panel of gram positive, gram negative, and resistant bacteria.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-04T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Danielle E. Talbot</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Caroline M. Casey</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elise L. Bezold</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kelsi Membrino</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alina Y. Muldagaliyeva</creator><creator xmlns="http://purl.org/dc/elements/1.1/">William M. Wuest</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kevin P. C. Minbiole</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01005E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01005E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01005E</link><title>Discovery of GBA-16-24 as a highly potent, selective ATR inhibitor for the treatment of FLT3-mutated acute myeloid leukemia</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01005E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2081-2095&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01005E, Research Article&lt;/div&gt;&lt;div&gt;Ping Li, Haiyan Ren, Xinyan Lan, Junfei Li, Zhi Liu, Huashuo Liu, Zhijie Zheng, Tianyan Zeng, Peili Wang, Mingyang Sun, Lei Xu, Yanyan Zhang, Yubo Zhou, Jia Li, Mingliang Wang, Kailong Jiang&lt;br/&gt;A novel and selective ATR inhibitor, &lt;strong&gt;GBA-16-24&lt;/strong&gt;, was developed. It exhibits potent synthetic lethality in FLT3-mutated AML and synergizes with clinical FLT3 inhibitors, proposing a promising combination therapy.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-03T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Ping Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Haiyan Ren</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xinyan Lan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Junfei Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhi Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Huashuo Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhijie Zheng</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tianyan Zeng</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Peili Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mingyang Sun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lei Xu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yanyan Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yubo Zhou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jia Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mingliang Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kailong Jiang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01138H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01138H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01138H</link><title>Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1H)-quinoline-O-carbamate derivatives as AChE/MAO-B dual inhibitors for the treatment of Alzheimer's disease</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01138H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2096-2112&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01138H, Research Article&lt;/div&gt;&lt;div&gt;Wenling Fu, Keren Wang, Hongsong Chen, Taoyi Liu, Xiaojuan Liu, Qishun Jin, Zhenghuai Tan, Wu Dong, Wenmin Liu, Zhipei Sang&lt;br/&gt;Based on the MTDL strategy, a dual AChE/MAO-B inhibitor &lt;strong&gt;3c&lt;/strong&gt; was obtained. &lt;strong&gt;3c&lt;/strong&gt; presented good BBB permeability and significant efficacy &lt;em&gt;in vivo&lt;/em&gt;.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-27T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Wenling Fu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Keren Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hongsong Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Taoyi Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiaojuan Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qishun Jin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhenghuai Tan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wu Dong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wenmin Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhipei Sang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01174D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01174D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01174D</link><title>New series of pentamidine-based 1,2,3-triazole-diaryl-hydrazones: design, synthesis, and evaluation of their leishmanicidal activity and mechanism of action against Leishmania (L.) amazonensis</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01174D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2157-2169&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01174D, Research Article&lt;/div&gt;&lt;div&gt;Patrícia F. Espuri Sepini, Vanessa Silva Gontijo, Laiane Mota Tavares, Leonardo Maciel Souza, Thalles H. F. Souza, Dyecika S. Couto, Juliana B. Nunes, Catarina Azevedo Ribeiro, Sara M. Mendonça da Silva Cravo, Bruno Zavan, Marina A. Alves, Hygor M. R. Souza, Marisa Ionta, Maria Emília Sousa, Eduardo F. Peloso, Marcos J. Marques, Claudio Viegas Jr.&lt;br/&gt;New series of pentamidine-based 1,2,3-triazole-diaryl-hydrazones was designed, synthesized, and evaluated against &lt;em&gt;L. amazonensis&lt;/em&gt;, with &lt;strong&gt;PQM-150&lt;/strong&gt; as the most potent multifunctional compound.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-27T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Patrícia F. Espuri Sepini</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vanessa Silva Gontijo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Laiane Mota Tavares</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Leonardo Maciel Souza</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thalles H. F. Souza</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dyecika S. Couto</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Juliana B. Nunes</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Catarina Azevedo Ribeiro</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sara M. Mendonça da Silva Cravo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bruno Zavan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marina A. Alves</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hygor M. R. Souza</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marisa Ionta</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Maria Emília Sousa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Eduardo F. Peloso</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marcos J. Marques</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Claudio Viegas Jr.</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01139F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01139F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01139F</link><title>1,3,4-Oxadiazole derivatives: targeting multiple bacterial pathways</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01139F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1867-1887&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01139F, Review Article&lt;/div&gt;&lt;div&gt;Pankaj Gupta, Sangeeta Verma, Rakesh Narang, Bhupesh Sharma, Vikramjeet Singh, Sukhbir Lal&lt;br/&gt;1,3,4-oxadiazole-based compounds exhibited antibacterial activity through inhibition of various essential bacterial cell components or pathways.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-25T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Pankaj Gupta</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sangeeta Verma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rakesh Narang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bhupesh Sharma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vikramjeet Singh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sukhbir Lal</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00006A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00006A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00006A</link><title>In vitro and in vivo studies of dehydroxylated-isoquines and -isotebuquines against trypanosomatids: a preclinical drug candidate for treatment of cutaneous leishmaniasis</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00006A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2015-2035&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00006A, Research Article&lt;/div&gt;&lt;div&gt;Angel H. Romero, Elva Serna, Elena Aguilera, Belen Davila, Francisco Delgado, Gonzalo Scalese, Leticia Pérez-Díaz, Gloria Yaluff, Noris Rodríguez, Hugo Cerecetto&lt;br/&gt;A promising candidate based on dehydroxylated isotebuquine against cutaneous leishmaniasis was identified, with high &lt;em&gt;in vitro&lt;/em&gt; activity against intracellular forms, adequate ADME-properties and drug-likeness parameters and good &lt;em&gt;in vivo&lt;/em&gt; efficacy.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-24T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Angel H. Romero</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elva Serna</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elena Aguilera</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Belen Davila</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Francisco Delgado</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gonzalo Scalese</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Leticia Pérez-Díaz</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gloria Yaluff</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Noris Rodríguez</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hugo Cerecetto</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01027F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01027F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01027F</link><title>Adamantane-based inhibitors of the influenza A M2 proton channel: structure-based design, biological evaluation, and synthetic approaches</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01027F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1811-1846&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01027F, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Marianna Stampolaki, Maria-Eleni Kouridaki, Kyriakos Georgiou, Antonios Kolocouris&lt;br/&gt;Experimental structures and accurate simulations can guide the design and synthesis of adamantanamines that can block AM2 wild-type and mutant AM2-mediated proton conductance.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-23T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Marianna Stampolaki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Maria-Eleni Kouridaki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kyriakos Georgiou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Antonios Kolocouris</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00007J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00007J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00007J</link><title>ZRMQ-22, a novel DYRK1A inhibitor, attenuates neuroinflammation and cognitive impairments in LPS-induced mice: a potential strategy for Alzheimer's disease</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00007J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2036-2052&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00007J, Research Article&lt;/div&gt;&lt;div&gt;Mengyu Ren, Huanhua Chen, Zhenshu Li, Jiacheng Zhuang, Aizhu Yang, Xiangdong Li, Xinyu Li, Xinpeng Wang, Zonghe Xu, Xianghuan Liu, Jiawen Song, Tianhao Jiang, Zihua Xu, Xudong Gao, Qingchun Zhao&lt;br/&gt;Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by irreversible cognitive decline and memory loss.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-20T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mengyu Ren</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Huanhua Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhenshu Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiacheng Zhuang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Aizhu Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiangdong Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xinyu Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xinpeng Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zonghe Xu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xianghuan Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiawen Song</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tianhao Jiang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zihua Xu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xudong Gao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qingchun Zhao</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00963D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00963D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00963D</link><title>PROTAC-mediated multi-target protein degradation in Alzheimer's disease: mechanistic insights, therapeutic applications, and translational challenges</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00963D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1847-1866&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00963D, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Bin Wang, Yunan Li, Tingting Yao, Xinai Shen, Huan Li, Wei Jiang, Xinuo Li, Zheying Zhu&lt;br/&gt;Clearing pathological proteins in Alzheimer's disease &lt;em&gt;via&lt;/em&gt; PROTAC-induced degradation.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-20T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Bin Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yunan Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tingting Yao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xinai Shen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Huan Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wei Jiang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xinuo Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zheying Zhu</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01113B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01113B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01113B</link><title>PROTAC approaches against drug-resistant EGFRC797S/L858R/T790M mutants: biological evaluation and SAR studies (2020–2025)</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01113B" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1888-1906&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01113B, Review Article&lt;/div&gt;&lt;div&gt;Ankush Kumar, Vishakha Sharma, Pallvi Kumari, Rajwinder Kaur, Rohit Bhatia&lt;br/&gt;The development of EGFR&lt;small&gt;&lt;sup&gt;C797S/L858R/T790M&lt;/sup&gt;&lt;/small&gt; mutation has become a major barrier to tyrosine kinase inhibitors.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-18T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Ankush Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vishakha Sharma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Pallvi Kumari</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rajwinder Kaur</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rohit Bhatia</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01165E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01165E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01165E</link><title>Design, synthesis and exploration of cyclic imides as PDE4 inhibitors in psoriasis</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01165E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1968-1988&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01165E, Research Article&lt;/div&gt;&lt;div&gt;Veena K. S., Pallabi Panja, Tirtha Nath, V. G. M. Naidu, Kalyan K. Sethi&lt;br/&gt;Twenty cyclic imide derivatives were synthesized and tested for their PDE4B inhibition potential. The best molecule selected was further evaluated for its anti-inflammatory property &lt;em&gt;in vitro&lt;/em&gt; and PDE4B selectivity &lt;em&gt;in silico&lt;/em&gt;.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-13T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Veena K. S.</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Pallabi Panja</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tirtha Nath</creator><creator xmlns="http://purl.org/dc/elements/1.1/">V. G. M. Naidu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kalyan K. Sethi</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00916B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00916B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00916B</link><title>Antibacterial peptidomimetics via fragment display on small-molecule scaffolds</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00916B" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1989-2001&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00916B, Research Article&lt;/div&gt;&lt;div&gt;Emma Dyhr, Lucía Cañete de Pinedo, Nicki Frederiksen, Martin Saxtorph Bojer, Hanne Ingmer, Ingvill Pedersen Sæbø, Synnøve Brandt Ræder, Magnar Bjørås, Emily Helgesen, James Alexander Booth, Henrik Franzyk&lt;br/&gt;In response to the growing threat of antimicrobial resistance, scaffold-based peptidomimetics were explored as potential antibacterial agents.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-13T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Emma Dyhr</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lucía Cañete de Pinedo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nicki Frederiksen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Martin Saxtorph Bojer</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hanne Ingmer</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ingvill Pedersen Sæbø</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Synnøve Brandt Ræder</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Magnar Bjørås</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Emily Helgesen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">James Alexander Booth</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Henrik Franzyk</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00685F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00685F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00685F</link><title>Synthesis and evaluation of 14β-acyl substituted 17-cyclopropylmethyl-7,8-dihydromorphinone derivatives: mixed partial agonists at mu opioid and nociception/orphanin FQ peptide receptors</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00685F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1950-1960&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00685F, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Mehrnoosh Ostovar, Keith Olsen, Gerta Cami-Kobeci, John R. Traynor, Luka Jeramaz, Stewart B. Kirton, Stephen M. Husbands&lt;br/&gt;The development of a new series of mixed mu/nociceptin opioid partial agonists as analgesics with a greatly improved safety profile.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-12T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mehrnoosh Ostovar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Keith Olsen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gerta Cami-Kobeci</creator><creator xmlns="http://purl.org/dc/elements/1.1/">John R. Traynor</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Luka Jeramaz</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Stewart B. Kirton</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Stephen M. Husbands</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00984G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00984G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00984G</link><title>Biocompatible de novo indolylchalcones as platelet aggregation inhibition and diabetic wound healing agents</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00984G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1916-1937&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00984G, Research Article&lt;/div&gt;&lt;div&gt;Sumit Kumar, Radhika Chaurasia, Gaurav Kumar, Arun K. Sharma, Ijaz Ahmed, Alam Nur-E-Kamal, Monalisa Mukherjee, Brajendra K. Singh, Virinder S. Parmar&lt;br/&gt;Biocompatible &lt;em&gt;de novo&lt;/em&gt; indolylchalcones exhibit anti-platelet aggregation and nitric oxide-mediated effects. They show antiplatelet activity and accelerated diabetic wound healing, indicating promise for diabetic wounds and cardiovascular therapy.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-11T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Sumit Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Radhika Chaurasia</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gaurav Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Arun K. Sharma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ijaz Ahmed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alam Nur-E-Kamal</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Monalisa Mukherjee</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Brajendra K. Singh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Virinder S. Parmar</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01140J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01140J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01140J</link><title>Verbenone-based selenophene derivatives as potential anti-cancer agents: synthesis and biological evaluation in 2D and 3D A549 cell models</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01140J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2130-2143&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01140J, Research Article&lt;/div&gt;&lt;div&gt;Jiale Han, Wei Shi, Min Hu, Wei Liu, Hongmei Wu, Biao Xiong, Xiaodong Qiu, Yunyun Wang&lt;br/&gt;Compound &lt;strong&gt;2R&lt;/strong&gt;, a verbenone–selenophene hybrid, selectively inhibits A549 cells &lt;em&gt;via&lt;/em&gt; ROS-mediated mitochondrial dysfunction, apoptosis and G0/G1 arrest, with efficacy confirmed in a 3D tumor spheroid model.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-11T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Jiale Han</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wei Shi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Min Hu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wei Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hongmei Wu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Biao Xiong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiaodong Qiu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yunyun Wang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01026H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01026H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01026H</link><title>Emerging strategies for Alzheimer's disease: leveraging flavonoid derivatives for early diagnosis and neuroprotection</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01026H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1771-1793&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01026H, Review Article&lt;/div&gt;&lt;div&gt;Zhe Han, Wenling Fu, Mingjuan Dai, Roujun Lu, Jianhua Yu, Wu Dong, Zhipei Sang&lt;br/&gt;Alzheimer's disease (AD) is a prevalent chronic and progressive neurodegenerative disorder predominantly affecting the elderly population.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-11T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Zhe Han</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wenling Fu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mingjuan Dai</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Roujun Lu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jianhua Yu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wu Dong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhipei Sang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01167A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01167A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01167A</link><title>Harnessing oligonucleotide architecture for potent multivalent inhibition of human carbonic anhydrases</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01167A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1961-1967&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01167A, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Eslam M. Abbass, Federico Ladu, Justine Mansot, Mathieu Noël, Alessio Nocentini, Mario Sechi, Claudiu T. Supuran, Michael Smietana, Jean-Yves Winum&lt;br/&gt;This study introduces oligonucleotides as spatially defined multivalent platforms for carbonic anhydrase inhibitor design.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-06T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Eslam M. Abbass</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Federico Ladu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Justine Mansot</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mathieu Noël</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alessio Nocentini</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mario Sechi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Claudiu T. Supuran</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Michael Smietana</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jean-Yves Winum</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00004E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00004E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00004E</link><title>Discovery of novel coumarin amphiphiles: dual-action antimicrobials with bacteria-mediated biofilm disruption and host-directed immunomodulation</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00004E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1938-1949&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00004E, Research Article&lt;/div&gt;&lt;div&gt;Haiyang Zhang, Qun Tang, Qian Zhu, Weiwei Xu, Zhihao Wang, Zirui Jiao, Jiakun Zuo, Wei Jiang, Cuiqin Huang, Huifang Yin, Xiangan Han, Wen Zhou&lt;br/&gt;Coumarin-derived amphipathic compounds were synthesised. Compound &lt;strong&gt;15&lt;/strong&gt; shows potent anti-&lt;em&gt;S. aureus&lt;/em&gt;, anti-biofilm and &lt;em&gt;in vivo&lt;/em&gt; activities as a potential candidate.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-02T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Haiyang Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qun Tang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qian Zhu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Weiwei Xu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhihao Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zirui Jiao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiakun Zuo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wei Jiang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Cuiqin Huang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Huifang Yin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiangan Han</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wen Zhou</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00943J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00943J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00943J</link><title>Discovery of a CHI3L1-targeted small molecule modulating neuroinflammation in Alzheimer's disease via DNA-encoded library (DEL) screening</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00943J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,1907-1915&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00943J, Research Article&lt;/div&gt;&lt;div&gt;Baljit Kaur, Longfei Zhang, Hossam Nada, Laura Calvo-Barreiro, Moustafa T. Gabr&lt;br/&gt;Chitinase-3-like protein 1 (CHI3L1, also known as YKL-40) has emerged as a central effector of astrocyte-mediated neuroinflammation and a promising biomarker for Alzheimer's disease (AD).&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-01-27T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Baljit Kaur</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Longfei Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hossam Nada</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Laura Calvo-Barreiro</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Moustafa T. Gabr</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00742A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00742A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00742A</link><title>Structure-guided optimisation of fenofibrate-derived oxidative phosphorylation inhibitors to modify tumour hypoxia</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00742A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00742A, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;James P. Holt-Martyn, Nicole Machado, James T. T. Coates, Rathi Puliyadi, Thomas Ashton, Elysia Traynor, Samina Aslam, Thomas K. Wise, Gonzalo Rodriguez-Berriguete, Christopher J. Schofield, Geoff S. Higgins&lt;br/&gt;Hypoxia, or low levels of oxygen, is a common feature of solid tumours that makes them resistant to cancer therapies. Electron transport chain inhibitors are a promising strategy for O&lt;small&gt;&lt;sub&gt;2&lt;/sub&gt;&lt;/small&gt; redistribution to target tumour hypoxia during radiotherapy.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-28T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">James P. Holt-Martyn</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nicole Machado</creator><creator xmlns="http://purl.org/dc/elements/1.1/">James T. T. Coates</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rathi Puliyadi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thomas Ashton</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elysia Traynor</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Samina Aslam</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thomas K. Wise</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gonzalo Rodriguez-Berriguete</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Christopher J. Schofield</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Geoff S. Higgins</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01089F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01089F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01089F</link><title>Sulfone and Sulfoxide-containing Pharmaceuticals: Targets, Pharmacological Properties and SAR Studies</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01089F, Review Article&lt;/div&gt;&lt;div&gt;Yunfei Du, Yiyang Zhou, Jinqu Li, Yiou Mei, Yuzhu Chen, Fengxia Sun&lt;br/&gt;Sulfone/sulfoxide functional groups are extremely important functional groups widely utilized in the design of biologically active drugs. Pharmaceuticals incorporating sulfone/sulfoxide have shown a broad spectrum of pharmacological properties, including anti-inflammatory,...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-28T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Yunfei Du</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yiyang Zhou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jinqu Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yiou Mei</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yuzhu Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fengxia Sun</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00800J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00800J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00800J</link><title>Design, synthesis, and anticancer evaluation of novel pyrrole–pyrazoline/chalcone hybrids: in vitro and computational insights into EGFR inhibition</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00800J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00800J, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Mansour S. Alturki, Marwa F. Ahmed, Abdulaziz H. Al Khzem, Mohamed S. Gomaa, Mohammad Sarafroz, Nada Tawfeeq, Mashael M. Alharbi, Abdulaziz K. Al Mouslem, Mohammed F. Aldawsari, Wajin R. Alruwili, Shah Alam Khan, Radwan El-Haggar, Atiah H. Almalki&lt;br/&gt;Design, synthesis, and biological evaluation of pyrazoline–pyrrole hybrids led to the identification of compound &lt;strong&gt;6b&lt;/strong&gt; as a potent EGFR inhibitor with significant antiproliferative activity against MCF-7 cells.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-27T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mansour S. Alturki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marwa F. Ahmed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Abdulaziz H. Al Khzem</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed S. Gomaa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohammad Sarafroz</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nada Tawfeeq</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mashael M. Alharbi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Abdulaziz K. Al Mouslem</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohammed F. Aldawsari</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wajin R. Alruwili</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shah Alam Khan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Radwan El-Haggar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Atiah H. Almalki</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00185H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00185H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00185H</link><title>New Terpenyl-Cinnamoyl-Hydrazone Analogues of Cannabidiol with Potent Antinociceptive Effect</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00185H, Research Article&lt;/div&gt;&lt;div&gt;João Pedro Barros de Paiva, Anna Carolina Pereira Lontra, Rachel Marins Campos, Eduardo  Araújo, Thaís Biondino Sardella Giorno, Mikaela  Lucinda de Souza, Graziella Dos Reis Rosa Franco, Claudio Viegas, Jr., Patricia Dias Fernandes&lt;br/&gt;In this study, novel terpenyl-cinnamoyl-hydrazone analogs were synthesized and evaluated for antinociceptive potential in preclinical nociception models. The compounds were tested in chemical (formalin-induced licking) and thermal (hot plate) assays...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">João Pedro Barros de Paiva</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anna Carolina Pereira Lontra</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rachel Marins Campos</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Eduardo  Araújo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Thaís Biondino Sardella Giorno</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mikaela  Lucinda de Souza</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Graziella Dos Reis Rosa Franco</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Claudio Viegas, Jr.</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Patricia Dias Fernandes</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00120C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00120C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00120C</link><title>Addressing Multidrug-resistant Bacterial Infections with Iridium-based Theragnostic Agents</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00120C, Research Article&lt;/div&gt;&lt;div&gt;Rama Karn, Mahesmita Sahoo, Sayantani Biswas, Suravi Chauhan, Ajay Kumar  Nag, Soham  Basu, Srikanta Patra, Debasis Manna&lt;br/&gt;Effective strategies are essential for addressing bacterial infections caused by antimicrobial resistance (AMR). The increasing interest in transition-metal complexes stems from their fluorescence properties and diverse mechanisms of action against...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Rama Karn</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mahesmita Sahoo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sayantani Biswas</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Suravi Chauhan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ajay Kumar  Nag</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Soham  Basu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Srikanta Patra</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Debasis Manna</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00025H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00025H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00025H</link><title>Design, synthesis and pharmacological evaluation of 3H-spiro[benzofuran-2,4′-piperidine] IRAK4 inhibitors for the treatment of diffuse large B-cell lymphoma</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00025H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00025H, Research Article&lt;/div&gt;&lt;div&gt;Zhiwei Chen, Qi Zhang, Yun Chen, Yi Ning, Q-i Zhang, Mengxiao Zhang, Qiupei Liu, Yi Xue, Linjiang Tong, Jian Ding, Hua Xie, Wenhu Duan&lt;br/&gt;We report the discovery of a new series of 3&lt;em&gt;H&lt;/em&gt;-spiro[benzofuran-2,4′-piperidine] IRAK4 inhibitors as potential anti-DLBCL agents.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Zhiwei Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qi Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yun Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yi Ning</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Q-i Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mengxiao Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qiupei Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yi Xue</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Linjiang Tong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jian Ding</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hua Xie</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wenhu Duan</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01082A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01082A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01082A</link><title>Lead optimization of 5jc21 (CG13250), a quinolin-2(1H)-one-based inhibitor of the BRD4 member of the bromodomain and extraterminal (BET) family of proteins</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01082A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01082A, Research Article&lt;/div&gt;&lt;div&gt;Jay Chauhan, Sarah Pogash, Makoto Yoshioka, Mithun Raje, Daniel Van Eker, Jeffrey W. Strovel, Steven Fletcher&lt;br/&gt;4,6-Disubstituted quinolinones are potent BRD4 inhibitors.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Jay Chauhan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sarah Pogash</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Makoto Yoshioka</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mithun Raje</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Daniel Van Eker</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jeffrey W. Strovel</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Steven Fletcher</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00115G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00115G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00115G</link><title>Diverse ring architectures of cyclic peptidomimetics targeting melanocortin receptors</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00115G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00115G, Review Article&lt;/div&gt;&lt;div&gt;Wenxiao K. Yue, Nicholas Barlow, Philip E. Thompson&lt;br/&gt;A review of the many types of macrocyclic melanocortin peptides. We show that there is a historical gap in the evaluation of these architectures in terms of their influence upon potency, selectivity and pharmacokinetics.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-21T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Wenxiao K. Yue</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nicholas Barlow</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Philip E. Thompson</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00165C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00165C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00165C</link><title>Quinoline/thiazole compounds as selective acetylcholinesterase inhibitors: synthesis and biological assessment</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00165C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00165C, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Berkant Kurban, Derya Osmaniye, Serkan Levent, Yusuf Özkay, Zafer Asım Kaplancıklı&lt;br/&gt;Acetylcholine (ACh), acetylcholinesterase enzyme (AChE), and AChE inhibition are of great importance in the treatment of neurodegenerative diseases.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-07T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Berkant Kurban</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Derya Osmaniye</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Serkan Levent</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yusuf Özkay</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zafer Asım Kaplancıklı</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00026F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00026F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00026F</link><title>D-Galactose-conjugated pyrimidine thioureas as potent antimicrobial agents: rapid green synthesis, structure–activity relationships and molecular modelling</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00026F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00026F, Research Article&lt;/div&gt;&lt;div&gt;Nguyen Dinh Thanh, Vu Ngoc Toan, Ngo Hong Anh Thu, Nguyen Minh Tri, Duong Ngoc Toan, Hoang Thi Kim Van&lt;br/&gt;&lt;small&gt;D&lt;/small&gt;-Galactose–pyrimidine thioureas were synthesized &lt;em&gt;via&lt;/em&gt; a recyclable ionic liquid–microwave method in high yields. Several derivatives showed broad-spectrum antimicrobial activity, and docking with ADMET predicted strong binding and drug-like properties.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-25T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Nguyen Dinh Thanh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vu Ngoc Toan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ngo Hong Anh Thu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nguyen Minh Tri</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Duong Ngoc Toan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hoang Thi Kim Van</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00243A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00243A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00243A</link><title>Emerging Cellular Uptake Mechanisms of bRo5 PROTACs</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00243A, Review Article&lt;/div&gt;&lt;div&gt;Toshihiko Tashima&lt;br/&gt;Proteolysis-targeting chimeras (PROTACs) predominantly occupy beyond-Rule-of-5 (bRo5) chemical space, where the mechanisms governing their cellular uptake remain incompletely understood and are not captured by classical models of passive membrane diffusion....&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-23T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Toshihiko Tashima</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00217J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00217J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00217J</link><title>Bicyclic monoterpenoid-based orthopoxvirus inhibitors: design, synthesis, and biological assessment of a novel amide series</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00217J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00217J, Research Article&lt;/div&gt;&lt;div&gt;Serafim A. Tishchenko, Anastasiya S. Sokolova, Valeriya V. Samsonova, Julia G. Pushkareva, Nikolay I. Bormotov, Ivan A. Moskalev, Daria. E. Solomina, Artem D. Rogachev, Alina V. Fatyanova, Sophia S. Borisevich, Olga I. Yarovaya, Olga A. Serova, Alena S. Ovchinnikova, Alexander A. Sergeev, Larisa N. Shishkina, Artemiy A. Sergeev, Alexander P. Agafonov, Nariman F. Salakhutdinov&lt;br/&gt;This study reports the design, synthesis, and comprehensive biological evaluation of a new class of orthopoxvirus inhibitors utilizing natural bicyclic monoterpenoid scaffolds as strategic replacements for synthetic polycyclic cores.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-09T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Serafim A. Tishchenko</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anastasiya S. Sokolova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Valeriya V. Samsonova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Julia G. Pushkareva</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nikolay I. Bormotov</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ivan A. Moskalev</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Daria. E. Solomina</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Artem D. Rogachev</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alina V. Fatyanova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sophia S. Borisevich</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Olga I. Yarovaya</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Olga A. Serova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alena S. Ovchinnikova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alexander A. Sergeev</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Larisa N. Shishkina</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Artemiy A. Sergeev</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alexander P. Agafonov</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nariman F. Salakhutdinov</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00132G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00132G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00132G</link><title>Regioselective Triclocarban-Catalyzed Synthesis of Spiroindeno- and Spirooxindolo-Pyrrolizidines with Apoptosis Induction in MCF-7 Cells</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00132G, Research Article&lt;/div&gt;&lt;div&gt;V Rukyanaik, Samata Pradhan, Chandraiah Godugu, Srinu Tothadi, Kadiyam Rama Krishna, Ravinder Pawar, Srinivas  Basavoju&lt;br/&gt;Design of new molecules from known structural motifs via [3+2] cycloaddition is a widely used strategy in modern drug discovery. Herein, an efficient, eco-friendly synthesis of spiroindeno- and spirooxindolo-pyrrolizidine derivatives...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-22T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">V Rukyanaik</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Samata Pradhan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Chandraiah Godugu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Srinu Tothadi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kadiyam Rama Krishna</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ravinder Pawar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Srinivas  Basavoju</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00022C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00022C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00022C</link><title>Pyrazole–triazole hybrids as kinase-triad inhibitors: a triple-target strategy for synergistic anticancer therapy</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00022C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00022C, Research Article&lt;/div&gt;&lt;div&gt;Mahmoud S. Elkotamy, Mohamed K. Elgohary, Mariam M. Fakhry, Mohamed E. Albakri, Abdelrahman A. Naglah, Abdulrahman A. Almehizia, Ahmed M. Naglah, Mohamed Fares, Haytham O. Tawfik, Wagdy M. Eldehna, Hatem A. Abdel-Aziz&lt;br/&gt;The ongoing issue of drug resistance and the lack of specificity in existing cancer treatments highlight the necessity for innovative multi-target agents.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-22T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mahmoud S. Elkotamy</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed K. Elgohary</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mariam M. Fakhry</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed E. Albakri</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Abdelrahman A. Naglah</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Abdulrahman A. Almehizia</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed M. Naglah</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed Fares</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Haytham O. Tawfik</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wagdy M. Eldehna</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hatem A. Abdel-Aziz</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00194G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00194G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00194G</link><title>A new class of Indole-based HDAC8 inhibitors as potential anti-lung cancer agents: In silico design, synthesis, biological assessment and binding interaction analysis</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00194G, Research Article&lt;/div&gt;&lt;div&gt;SAMIMA KHATUN, Venkatesh Muthukumar, Ambati  Himaja, Indrasis Dasgupta, Kalpataru Das, Balaram Ghosh, Shovanlal Gayen&lt;br/&gt;A novel series of indole-based hydroxamic acids was designed, synthesized, and evaluated as promising HDAC8 inhibitors for lung cancer therapy. In silico analyses, including classification-based QSAR, chemical space networks, and...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-22T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">SAMIMA KHATUN</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Venkatesh Muthukumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ambati  Himaja</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Indrasis Dasgupta</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kalpataru Das</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Balaram Ghosh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shovanlal Gayen</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01001B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01001B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01001B</link><title>Design, synthesis, and biological evaluation of quinoline derivatives as dual-target inhibitors of chitin synthase and glucosamine-6-phosphate synthase</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01001B" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01001B, Research Article&lt;/div&gt;&lt;div&gt;Nan Wang, Lige Liu, Tao Liu, Hong Luo, Yan Long, Xinlong Yang, Youli Zhang, Qinggang Ji&lt;br/&gt;This study designed and synthesized a series of glycine methyl ester quinoline derivatives as dual-target inhibitors of CHS and GlmS, followed by biological evaluation including enzyme inhibition assays and &lt;em&gt;in vitro&lt;/em&gt; antifungal activity testing.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-26T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Nan Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lige Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tao Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hong Luo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yan Long</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xinlong Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Youli Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qinggang Ji</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00148C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00148C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00148C</link><title>Novel zerumbone-amide-triazole hybrids as potential NF-κB pathway inhibitors: design, synthesis, cytotoxicity evaluation, computational studies, and mechanistic insights</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00148C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00148C, Research Article&lt;/div&gt;&lt;div&gt;Pham The Chinh, Pham Thi Tham, Vu Thi Lien, Dao Thi Nhung, Le Thi Thuy Loan, Khieu Thi Tam, Vu Tuan Kien, Cao Thanh Hai, Phan Thanh Phuong, Truong Thi Thao, Vuong Truong Xuan, Le Thi Lien&lt;br/&gt;A series of fifteen novel zerumbone-amide-triazole hybrids &lt;strong&gt;12a–i&lt;/strong&gt; and &lt;strong&gt;15a–f&lt;/strong&gt; were successfully designed and synthesized from azazerumbone II (&lt;strong&gt;2&lt;/strong&gt;) &lt;em&gt;via&lt;/em&gt; click reaction.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-26T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Pham The Chinh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Pham Thi Tham</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vu Thi Lien</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dao Thi Nhung</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Le Thi Thuy Loan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Khieu Thi Tam</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vu Tuan Kien</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Cao Thanh Hai</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Phan Thanh Phuong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Truong Thi Thao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vuong Truong Xuan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Le Thi Lien</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00221H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00221H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00221H</link><title>Synthesis-guided design and discovery of alkylated indoles with antibacterial activity against MRSA</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00221H, Research Article&lt;/div&gt;&lt;div&gt;Auqib Rashid, Vishwani Jamwal, Bilal A Bhat, KULJIT SINGH, Showkat  Rashid&lt;br/&gt;Substantially high morbidity and mortality rates are associated with antimicrobial resistance (AMR), which poses an alarming challenge to global healthcare. The causative, drug-resistant superbugs (headed by Staphylococcus aureus) adopt multiple...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-21T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Auqib Rashid</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vishwani Jamwal</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bilal A Bhat</creator><creator xmlns="http://purl.org/dc/elements/1.1/">KULJIT SINGH</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Showkat  Rashid</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01147G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01147G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01147G</link><title>Structure-based design of potent pyrazolo[1,5-a]pyrimidine CDK4/6 inhibitors: biological evaluation and computational validation</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01147G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01147G, Research Article&lt;/div&gt;&lt;div&gt;Faizah A. Binjubair, Mahmoud S. Elkotamy, Amr A. Mattar, Bjad K. Almutairy, Sara T. Al-Rashood, Mohamed M. Eldesouki, Jalloul Bouajila, Hatem A. Abdel-Aziz, Mariam M. Fakhry&lt;br/&gt;Structure-based design yielded potent CDK4/6 inhibitor &lt;strong&gt;19i&lt;/strong&gt;, inducing G1 cell-cycle arrest and apoptosis in HCT-116 cells, supported by enzymatic inhibition and molecular docking/dynamics studies.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-20T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Faizah A. Binjubair</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mahmoud S. Elkotamy</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Amr A. Mattar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bjad K. Almutairy</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sara T. Al-Rashood</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed M. Eldesouki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jalloul Bouajila</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hatem A. Abdel-Aziz</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mariam M. Fakhry</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00019C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00019C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00019C</link><title>Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00019C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00019C, Research Article&lt;/div&gt;&lt;div&gt;Dong Xu, Wenxiu Weng, Huining Cao, Chao Zhang, Yudi Zhang, Yan Li, Junhai Xiao, Hua Xie, Jialin Guo, Guoliang Chen&lt;br/&gt;Structure-based rational design yielded novel potent BCAT2 inhibitors &lt;strong&gt;C10&lt;/strong&gt; (IC&lt;small&gt;&lt;sub&gt;50&lt;/sub&gt;&lt;/small&gt; = 44 nM) and &lt;strong&gt;C11&lt;/strong&gt; (IC&lt;small&gt;&lt;sub&gt;50&lt;/sub&gt;&lt;/small&gt; = 54 nM), which exhibit 8–10-fold selectivity over BCAT1 and form stable, key interactions within the BCAT2 active pocket.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-20T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Dong Xu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wenxiu Weng</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Huining Cao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Chao Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yudi Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yan Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Junhai Xiao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hua Xie</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jialin Guo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Guoliang Chen</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01095K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01095K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01095K</link><title>Recent advances towards BACE1 drug discovery and therapeutics design</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01095K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01095K, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Saim Imran, Meera Patel, Meissam Noroozifar, Kagan Kerman&lt;br/&gt;We explored the latest developments in modulators, antibody therapy, and gene therapy targeting β-site amyloid precursor protein cleaving enzyme 1 (BACE1) to combat Alzheimer's disease.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-09T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Saim Imran</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Meera Patel</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Meissam Noroozifar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kagan Kerman</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00911A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00911A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00911A</link><title>Hypoxia-triggered dichloroacetate delivery with effective reversal of cancer cell reprogramming</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00911A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00911A, Research Article&lt;/div&gt;&lt;div&gt;Rensong Sun, Lei Wang, Ziang Liu, Hao Wu, Wanwan Wang, Yang Wang, Xiao Qian, Engin U. Akkaya&lt;br/&gt;The 3-methyl-2-nitroimidazole dichloroacetate derivative studied in this work is a prodrug version of dichloroacetate, and it is active at lower concentrations in hypoxic cell cultures and suppresses tumor progression significantly &lt;em&gt;in vivo&lt;/em&gt;.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-02T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Rensong Sun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lei Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ziang Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hao Wu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wanwan Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yang Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiao Qian</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Engin U. Akkaya</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00819K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00819K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00819K</link><title>Decoding the association of polycystic ovary syndrome with metabolic-associated fatty liver: insights into CK18 and LC3II/ATG7/P62 autophagy axis and adjunct therapeutics of metformin and levothyroxine</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00819K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00819K, Research Article&lt;/div&gt;&lt;div&gt;Sameeah Mejbel Hamad Algenabi, Anwar Nather Seiwan, Maha Hussein Hashem Sabra, Doaa I. Mohamed, Lobna Fouad Abd ElAziz Bassyouni, Dalia Alaa El-Din Aly El-Waseef, Samar F. Ezzat, Omnyah A. El-Kharashi, Hanaa F. Abd El-Kareem, Hyfa A. Alzahrani, Fawzyah Obeedallah Albaldi, Ahmed Shokry Elharoun, Mansour Altayyar, Amal Fahmy Dawood, Hebatallah H. Abo Nahas, Ahmed Abdel-Salam M. Elmelegy&lt;br/&gt;Metformin–levothyroxine synergistically treats PCOS-MAFLD. Reduced body/liver weight, ALT/AST/TSH/lipids, testosterone/LH/HOMA-IR. Increased estradiol. Suppressed autophagy (LC3II/ATG7/p62/CK18) and improved histology.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-13T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Sameeah Mejbel Hamad Algenabi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anwar Nather Seiwan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Maha Hussein Hashem Sabra</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Doaa I. Mohamed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lobna Fouad Abd ElAziz Bassyouni</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dalia Alaa El-Din Aly El-Waseef</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Samar F. Ezzat</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Omnyah A. El-Kharashi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hanaa F. Abd El-Kareem</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hyfa A. Alzahrani</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fawzyah Obeedallah Albaldi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed Shokry Elharoun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mansour Altayyar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Amal Fahmy Dawood</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hebatallah H. Abo Nahas</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed Abdel-Salam M. Elmelegy</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00084C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00084C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00084C</link><title>Beyond infection control: exploring the therapeutic potential of antimicrobials in oncology and their synthetic perspectives</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00084C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00084C, Review Article&lt;/div&gt;&lt;div&gt;Rahul Kumar, Mohd Yeshab Ansari&lt;br/&gt;This review explores the burgeoning potential of antimicrobial agents in oncology, highlighting their roles in reducing infection-related mortality, enhancing therapeutic effectiveness, and improving the overall quality of life in cancer patients.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-18T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Rahul Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohd Yeshab Ansari</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00097E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00097E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00097E</link><title>Phenoxyacetic acid scaffold as a platform for dual anticonvulsant and anti-inflammatory drug design</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00097E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00097E, Research Article&lt;/div&gt;&lt;div&gt;Mohamed K. Elgohary, Mahmoud Abdelrahman Alkabbani, Aya Mohamed Ahmed Ibrahim, Ahmed Elsonbaty, Mayada H. Mohamed, Abdulrahman A. Almehizia, Ahmed M. Naglah, Mohamed Fares, Hatem A. Abdel-Aziz&lt;br/&gt;Neuroinflammation is increasingly recognized as a critical contributor to epileptogenesis and antiepileptic drug resistance, emphasizing the need for multi-target therapeutic strategies.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-10T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed K. Elgohary</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mahmoud Abdelrahman Alkabbani</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Aya Mohamed Ahmed Ibrahim</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed Elsonbaty</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mayada H. Mohamed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Abdulrahman A. Almehizia</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed M. Naglah</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed Fares</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hatem A. Abdel-Aziz</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00076B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00076B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00076B</link><title>A Comprehensive Study of Novel Pregnenolone-Isoxazole Hybrids as Selective Inducers of Mitochondrial Apoptosis in Breast Cancer Cells</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00076B, Research Article&lt;/div&gt;&lt;div&gt;Victoria  Malakhova, Alexander  Scherbakov, Diana I. Salnikova, Alvina Khamidullina, Danila  Sorokin, Dmitry A. Vasilenko, Elena Chernoburova, Elena Averina, Igor V. Zavarzin, Yulia Volkova&lt;br/&gt;Heterocyclic derivatives of steroids have emerged as promising anticancer agents by concurrently targeting multiple pathways, including apoptosis induction, cell cycle arrest, and mitochondrial dysfunction. Here, we report novel pregnenolone-isoxazole hybrids...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-08T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Victoria  Malakhova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alexander  Scherbakov</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Diana I. Salnikova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alvina Khamidullina</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Danila  Sorokin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dmitry A. Vasilenko</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elena Chernoburova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elena Averina</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Igor V. Zavarzin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yulia Volkova</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00013D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00013D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00013D</link><title>Triclosan–isatin hybrids as potent anti-proliferative agents inducing S-phase arrest via DNA gyrase inhibition in triple-negative breast cancer</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00013D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00013D, Research Article&lt;/div&gt;&lt;div&gt; Shekhar, Asif Raza, Sukhmanpreet kaur, Amit Anand, Arun K. Sharma, Vipan Kumar&lt;br/&gt;A series of 1&lt;em&gt;H&lt;/em&gt;-1,2,3-triazole-tethered TCS–isatin hybrid compounds were synthesized and evaluated for their antiproliferative activity against triple-negative breast cancer (TNBC).&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-24T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/"> Shekhar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Asif Raza</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sukhmanpreet kaur</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Amit Anand</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Arun K. Sharma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vipan Kumar</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01173F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01173F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01173F</link><title>Redefining the role of the thiol-based agent N-acetylcysteine in human health and disease and elucidating potential advantages of its amide derivative</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01173F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01173F, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Hui-Qi Qu, Charlly Kao, Hakon Hakonarson&lt;br/&gt;&lt;em&gt;N&lt;/em&gt;-Acetylcysteine amide (NACA) reduces polarity and ionization relative to NAC, improving membrane permeability and intracellular exposure while preserving thiol-mediated redox activity and glutathione support.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-01T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Hui-Qi Qu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Charlly Kao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hakon Hakonarson</creator></item></channel></rss>